JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griner, R. D.
Right arrow Articles by Bollag, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griner, R. D.
Right arrow Articles by Bollag, W. B.

Vol. 294, Issue 3, 1219-1224, September 2000

Inhibition of [3H]Thymidine Transport Is a Nonspecific Effect of PDMP in Primary Cultures of Mouse Epidermal Keratinocytes1

Richard D. Griner and Wendy B. Bollag

Program in Cell Signaling, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia

Inhibitors of sphingolipid metabolism are frequently used to investigate the role of ceramide and other sphingolipids as intracellular signaling molecules. For example, the inhibitor of glucosylceramide synthase D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) is commonly used to deplete glycosphingolipids and increase ceramide levels. Ceramide is known to induce growth arrest and differentiation of keratinocytes, and we hypothesized that PDMP would increase ceramide levels and induce growth arrest of primary cultures of mouse epidermal keratinocytes. As expected, PDMP increased ceramide levels and decreased the incorporation of [3H]thymidine into DNA, but surprisingly, PDMP was found to rapidly inhibit the intracellular transport of [3H]thymidine. This is likely due to a direct effect on nucleoside transport by PDMP and not due to elevations in ceramide levels because increasing ceramide levels by the addition of exogenous sphingomyelinase had no effect on [3H]thymidine transport. Furthermore, it is unlikely that the decreased [3H]thymidine transport is in response to growth arrest because PDMP had no effect on the cell cycle profile of keratinocytes. These results reveal that PDMP inhibits nucleoside transport independent of effects on ceramide levels or cell growth but probably by a direct effect on the nucleoside transport apparatus. Thus, this compound may be unsuitable for investigating the role of ceramide or other sphingolipids in some cellular processes.


1 This work was supported in part by National Institutes of Health Grant AR45212.


0022-3565/00/2943-1219$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Cell Sci.Home page
T. Sprocati, P. Ronchi, A. Raimondi, M. Francolini, and N. Borgese
Dynamic and reversible restructuring of the ER induced by PDMP in cultured cells
J. Cell Sci., August 1, 2006; 119(15): 3249 - 3260.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
PNAS, February 6, 2002; (2002) 261710799.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
PNAS, February 19, 2002; 99(4): 2222 - 2227.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.